drugset / Trial / NCT01347203

A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting

NCT01347203 ↗

Phase 1 Completed 12 enrolled Diakron Pharmaceuticals
RandomizedCrossoverOpen-labelTreatment

Summary

This will be a study existing of 4 periods, to evaluate for a single dose of 4 different tablets of DPOC-4088 the absorption and elimination from the body and the potential effect on blood clotting. The differences between the tablets are the dose (100 or 200 mg) and the rate of release of DPOC-4088 from the tablet (16 or 20 hours). The allocation of the tablets in each period will be determined by chance but is known upfront.

Timeline

Start
2011-04
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DPOC-4088 Small molecule 100 mg Oral
Subject DPOC-4088 Small molecule 200 mg Oral